The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: Results from the REDUCE trial

Carcinogenesis

Volumn 34, Issue 6, 2013, Pages 1260-1264

  Chen, Zhuo ^a   Greenwood, Celia ^b,c   Isaacs, William B ^d   Foulkes, William D ^c   Sun, Jielin ^a   Zheng, Sigun L ^a   Condreay, Lynn D ^e   Xu, Jianfeng ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; AUSTRALIA; CANCER RISK; CONTROLLED STUDY; ETHNICITY; EUROPE; FAMILY HISTORY; FOLLOW UP; GENE FREQUENCY; GENE MUTATION; HETEROZYGOTE; HOMEOBOX B13 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE DIFFERENCE; SOUTH AFRICA; SOUTH AND CENTRAL AMERICA; TUMOR GENE;

5-ALPHA REDUCTASE INHIBITORS; AGED; AZASTEROIDS; FOUNDER EFFECT; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; MUTATION; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877248238     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt055     Document Type: Article

References (24)

1. Siegel,R. et al. (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA. Cancer J. Clin., 61, 212-236.
2. Crawford,E.D. (2003) Epidemiology of prostate cancer. Urology, 62(6 suppl. 1), 3-12.
3. Ewing,C.M. et al. (2012) Germline mutations in HOXB13 and prostatecancer risk. N. Engl. J. Med., 366, 141-149.
4. Breyer,J.P. et al. (2012) Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer. Cancer Epidemiol. Biomarkers Prev., 21, 1348-1353.
5. Akbari,M.R. et al. (2012) Association between germline HOXB13 G84E mutation and risk of prostate cancer. J. Natl. Cancer Inst., 104, 1260-1262.
6. Andriole,G. et al.; REDUCE Study Group. (2004) Chemoprevention of prostate cancer in men at high risk: rationale and design of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial. J. Urol., 172(4 Pt 1), 1314-1317.
7. Andriole,G.L. et al.; REDUCE Study Group. (2010) Effect of dutasteride on the risk of prostate cancer. N. Engl. J. Med., 362, 1192-1202.
8. Karlsson,R. et al. (2012) A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk. Eur. Urol. 2012 Jul 20. [Epub ahead of print].
9. Purcell,S. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
10. Kumar,S. et al. (1994) MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers. Comput. Appl. Biosci., 10, 189-191.
11. Saitou,N. et al. (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol., 4, 406-425.
12. Rzhetsky,A. et al. (1993) Theoretical foundation of the minimum-evolution method of phylogenetic inference. Mol. Biol. Evol., 10, 1073-1095.
13. Nei,M. et al. (2000) Molecular Evolution and Phylogenetics. Oxford University Press, New York, NY.
14. Reeve,J.P. et al. (2002) DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics, 18, 894-895.
15. Greenwood,C.M. et al. (2010) How old is this mutation? - a study of three Ashkenazi Jewish founder mutations. BMC Genet., 11, 39.
16. Kero,R. (1980) Migration from Finland 1866-1970. In Les Migrations Internationales de la Fin Du XVIII Éditions du Centre national de la recherche scientifique, Paris, France, pp. 392-400.
17. Eeles,R.A. et al.; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators; PRACTICAL Consortium. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat. Genet., 41, 1116-1121.
18. Eeles,R.A. et al.; UK Genetic Prostate Cancer Study Collaborators; British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet., 40, 316-321.
19. Gudmundsson,J. et al. (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat. Genet., 41, 1122-1126.
20. Gudmundsson,J. et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet., 39, 631-637.
21. Kote-Jarai,Z. et al.; UK Genetic Prostate Cancer Study Collaborators/ British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators, The Australian Prostate Cancer BioResource; PRACTICAL Consortium. (2011) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat. Genet., 43, 785-791.
22. Sun,J. et al. (2009) Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res., 69, 10-15.
23. Thomas,G. et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet., 40, 310-315.
24. Yeager,M. et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet., 39, 645-649.